BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

691 related articles for article (PubMed ID: 28973076)

  • 1. Effect of Dietary Supplementation With Lutein, Zeaxanthin, and ω-3 on Macular Pigment: A Randomized Clinical Trial.
    Korobelnik JF; Rougier MB; Delyfer MN; Bron A; Merle BMJ; Savel H; Chêne G; Delcourt C; Creuzot-Garcher C
    JAMA Ophthalmol; 2017 Nov; 135(11):1259-1266. PubMed ID: 28973076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma long-chain omega-3 polyunsaturated fatty acids and macular pigment in subjects with family history of age-related macular degeneration: the Limpia Study.
    Merle BMJ; Buaud B; Korobelnik JF; Bron A; Delyfer MN; Rougier MB; Savel H; Vaysse C; Creuzot-Garcher C; Delcourt C
    Acta Ophthalmol; 2017 Dec; 95(8):e763-e769. PubMed ID: 28271618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macular pigment density variation after supplementation of lutein and zeaxanthin using the Visucam
    Azar G; Quaranta-El Maftouhi M; Masella JJ; Mauget-Faÿsse M
    J Fr Ophtalmol; 2017 Apr; 40(4):303-313. PubMed ID: 28336284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum and retinal responses to three different doses of macular carotenoids over 12 weeks of supplementation.
    Stringham JM; Stringham NT
    Exp Eye Res; 2016 Oct; 151():1-8. PubMed ID: 27426932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term effects of lutein, zeaxanthin and omega-3-LCPUFAs supplementation on optical density of macular pigment in AMD patients: the LUTEGA study.
    Dawczynski J; Jentsch S; Schweitzer D; Hammer M; Lang GE; Strobel J
    Graefes Arch Clin Exp Ophthalmol; 2013 Dec; 251(12):2711-23. PubMed ID: 23695657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lutein, Zeaxanthin and Meso-zeaxanthin Supplementation Associated with Macular Pigment Optical Density.
    Ma L; Liu R; Du JH; Liu T; Wu SS; Liu XH
    Nutrients; 2016 Jul; 8(7):. PubMed ID: 27420092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.
    ; Chew EY; Clemons TE; Sangiovanni JP; Danis RP; Ferris FL; Elman MJ; Antoszyk AN; Ruby AJ; Orth D; Bressler SB; Fish GE; Hubbard GB; Klein ML; Chandra SR; Blodi BA; Domalpally A; Friberg T; Wong WT; Rosenfeld PJ; Agrón E; Toth CA; Bernstein PS; Sperduto RD
    JAMA Ophthalmol; 2014 Feb; 132(2):142-9. PubMed ID: 24310343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function: The AREDS2 Randomized Clinical Trial.
    Chew EY; Clemons TE; Agrón E; Launer LJ; Grodstein F; Bernstein PS;
    JAMA; 2015 Aug; 314(8):791-801. PubMed ID: 26305649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration.
    Ma L; Yan SF; Huang YM; Lu XR; Qian F; Pang HL; Xu XR; Zou ZY; Dong PC; Xiao X; Wang X; Sun TT; Dou HL; Lin XM
    Ophthalmology; 2012 Nov; 119(11):2290-7. PubMed ID: 22858124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot evaluation of short-term changes in macular pigment and retinal sensitivity in different phenotypes of early age-related macular degeneration after carotenoid supplementation.
    Corvi F; Souied EH; Falfoul Y; Georges A; Jung C; Querques L; Querques G
    Br J Ophthalmol; 2017 Jun; 101(6):770-773. PubMed ID: 27587715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes following supplementation with lutein and zeaxanthin in retinal function in eyes with early age-related macular degeneration: a randomised, double-blind, placebo-controlled trial.
    Huang YM; Dou HL; Huang FF; Xu XR; Zou ZY; Lu XR; Lin XM
    Br J Ophthalmol; 2015 Mar; 99(3):371-5. PubMed ID: 25228440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of macular pigment optical density in patients with dry and wet age-related macular degeneration.
    Ozyurt A; Kocak N; Akan P; Calan OG; Ozturk T; Kaya M; Karahan E; Kaynak S
    Indian J Ophthalmol; 2017 Jun; 65(6):477-481. PubMed ID: 28643712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epilutein for Early-Stage Age-Related Macular Degeneration: A Randomized and Prospective Study.
    Forte R; Panzella L; Cesarano I; Cennamo G; Eidenberger T; Napolitano A
    Ophthalmic Res; 2017; 58(4):231-241. PubMed ID: 28957818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973.
    Richer SP; Stiles W; Graham-Hoffman K; Levin M; Ruskin D; Wrobel J; Park DW; Thomas C
    Optometry; 2011 Nov; 82(11):667-680.e6. PubMed ID: 22027699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macular xanthophylls and ω-3 long-chain polyunsaturated fatty acids in age-related macular degeneration: a randomized trial.
    Arnold C; Winter L; Fröhlich K; Jentsch S; Dawczynski J; Jahreis G; Böhm V
    JAMA Ophthalmol; 2013 May; 131(5):564-72. PubMed ID: 23519529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescence lifetime imaging ophthalmoscopy and the influence of oral lutein/zeaxanthin supplementation on macular pigment (FLOS) - A pilot study.
    Jaggi D; Solberg Y; Dysli C; Lincke J; Habra O; Wyss A; Wolf S; Zinkernagel M
    Clin Nutr ESPEN; 2023 Aug; 56():127-134. PubMed ID: 37344061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral Lutein Supplementation Enhances Macular Pigment Density and Contrast Sensitivity but Not in Combination With Polyunsaturated Fatty Acids.
    Wolf-Schnurrbusch UE; Zinkernagel MS; Munk MR; Ebneter A; Wolf S
    Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):8069-74. PubMed ID: 26720458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
    Age-Related Eye Disease Study 2 Research Group
    JAMA; 2013 May; 309(19):2005-15. PubMed ID: 23644932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LAST II: Differential temporal responses of macular pigment optical density in patients with atrophic age-related macular degeneration to dietary supplementation with xanthophylls.
    Richer S; Devenport J; Lang JC
    Optometry; 2007 May; 78(5):213-9. PubMed ID: 17478338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study.
    Trieschmann M; Beatty S; Nolan JM; Hense HW; Heimes B; Austermann U; Fobker M; Pauleikhoff D
    Exp Eye Res; 2007 Apr; 84(4):718-28. PubMed ID: 17306793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.